PL1968957T3 - Podstawione tiazole i ich zastosowanie do wytwarzania środków leczniczych - Google Patents

Podstawione tiazole i ich zastosowanie do wytwarzania środków leczniczych

Info

Publication number: PL1968957T3
Authority: PL; Poland
Prior art keywords: propiolamide; substituted; definitions; thiazolylalkyl; diastereomers
Prior art date: 2005-12-28

Application number

PL06829855T

Other languages

English (en)

Inventor

Michael Haurand

Klaus Schiene

Sven Kühnert

Melanie Reich

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-28

Filing date

2006-12-22

Publication date

2010-06-30

2006-12-22 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2010-06-30 Publication of PL1968957T3 publication Critical patent/PL1968957T3/pl

Links

239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
150000003557 thiazoles Chemical class 0.000 title 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 abstract 2
108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 abstract 2
230000005764 inhibitory process Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
HCJTYESURSHXNB-UHFFFAOYSA-N propynamide Chemical class NC(=O)C#C HCJTYESURSHXNB-UHFFFAOYSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
HAHPBHFJWCOOHI-UHFFFAOYSA-N 3-phenyl-n-[1-(1,3-thiazol-2-yl)pyrrolidin-3-yl]prop-2-ynamide Chemical compound C=1C=CC=CC=1C#CC(=O)NC(C1)CCN1C1=NC=CS1 HAHPBHFJWCOOHI-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
230000002075 anti-alcohol Effects 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000001142 anti-diarrhea Effects 0.000 abstract 1
230000002460 anti-migrenic effect Effects 0.000 abstract 1
230000000648 anti-parkinson Effects 0.000 abstract 1
230000001139 anti-pruritic effect Effects 0.000 abstract 1
230000002738 anti-smoking effect Effects 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
229960003965 antiepileptics Drugs 0.000 abstract 1
239000000939 antiparkinson agent Substances 0.000 abstract 1
239000003908 antipruritic agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
230000033228 biological regulation Effects 0.000 abstract 1
230000001966 cerebroprotective effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000000324 neuroprotective effect Effects 0.000 abstract 1
230000001777 nootropic effect Effects 0.000 abstract 1
229940125725 tranquilizer Drugs 0.000 abstract 1
239000003204 tranquilizing agent Substances 0.000 abstract 1
230000002936 tranquilizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Hematology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Vascular Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)

PL06829855T 2005-12-28 2006-12-22 Podstawione tiazole i ich zastosowanie do wytwarzania środków leczniczych PL1968957T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102005062991A DE102005062991A1 (de)	2005-12-28	2005-12-28	Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
EP06829855A EP1968957B1 (de)	2005-12-28	2006-12-22	Substituierte thiazole und ihre verwendung zur herstellung von arzneimitteln
PCT/EP2006/012482 WO2007079960A1 (de)	2005-12-28	2006-12-22	Substituierte thiazole und ihre verwendung zur herstellung von arzneimitteln

Publications (1)

Publication Number	Publication Date
PL1968957T3 true PL1968957T3 (pl)	2010-06-30

Family

ID=37885773

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06829855T PL1968957T3 (pl)	2005-12-28	2006-12-22	Podstawione tiazole i ich zastosowanie do wytwarzania środków leczniczych

Country Status (13)

Country	Link
US (1)	US7871999B2 (pl)
EP (1)	EP1968957B1 (pl)
JP (1)	JP2009522222A (pl)
AT (1)	ATE455769T1 (pl)
CA (1)	CA2633731A1 (pl)
CY (1)	CY1110613T1 (pl)
DE (2)	DE102005062991A1 (pl)
DK (1)	DK1968957T3 (pl)
ES (1)	ES2339980T3 (pl)
PL (1)	PL1968957T3 (pl)
PT (1)	PT1968957E (pl)
SI (1)	SI1968957T1 (pl)
WO (1)	WO2007079960A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005062986A1 (de) *	2005-12-28	2007-07-05	Grünenthal GmbH	Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
DE102005062990A1 (de) *	2005-12-28	2007-07-05	Grünenthal GmbH	Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
FR2932483A1 (fr) *	2008-06-13	2009-12-18	Cytomics Systems	Composes utiles pour le traitement des cancers.
EP3846793B1 (en)	2018-09-07	2024-01-24	PIC Therapeutics, Inc.	Eif4e inhibitors and uses thereof
AR121506A1 (es)	2020-03-03	2022-06-08	Pic Therapeutics Inc	Inhibidores del eif4e y sus usos
US12157732B2 (en)	2021-08-25	2024-12-03	PIC Therapeutics, Inc.	eIF4E inhibitors and uses thereof
IL310924A (en)	2021-08-25	2024-04-01	Pic Therapeutics Inc	Eif4e inhibitors and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL153884A0 (en) *	2000-07-20	2003-07-31	Neurogen Corp	Capsaicin receptor ligands
WO2002068380A1 (en) *	2001-02-22	2002-09-06	Eli Lilly And Company	Synthetic excitatory amino acids
WO2003093236A1 (en) *	2002-05-02	2003-11-13	Euro-Celtique, S.A.	1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor
US20040127501A1 (en) *	2002-09-24	2004-07-01	Zhengming Chen	Therapeutic agents useful for treating pain
JP2006518368A (ja) *	2003-02-21	2006-08-10	ファイザー・インク	プロテインキナーゼ阻害剤としてのｎ−ヘテロシクリル置換アミノチアゾール誘導体
EP1603899B1 (en) *	2003-03-06	2009-08-26	Glaxo Group Limited	Heterocyclic urea derivatives for the treatment of pain
ES2322707T3 (es) *	2003-07-03	2009-06-25	Euro-Celtique S.A.	Derivados de 2-piridina alquino utiles para tratar el dolor.
WO2005035500A2 (en) *	2003-10-09	2005-04-21	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
GB0325956D0 (en) *	2003-11-06	2003-12-10	Addex Pharmaceuticals Sa	Novel compounds
DE102004032567A1 (de) *	2004-07-05	2006-03-02	Grünenthal GmbH	Substituierte 1-Propiolyl-piperazine

2005
- 2005-12-28 DE DE102005062991A patent/DE102005062991A1/de not_active Withdrawn
2006
- 2006-12-22 EP EP06829855A patent/EP1968957B1/de not_active Not-in-force
- 2006-12-22 PT PT06829855T patent/PT1968957E/pt unknown
- 2006-12-22 CA CA002633731A patent/CA2633731A1/en not_active Abandoned
- 2006-12-22 AT AT06829855T patent/ATE455769T1/de active
- 2006-12-22 WO PCT/EP2006/012482 patent/WO2007079960A1/de not_active Ceased
- 2006-12-22 PL PL06829855T patent/PL1968957T3/pl unknown
- 2006-12-22 DK DK06829855.3T patent/DK1968957T3/da active
- 2006-12-22 JP JP2008547891A patent/JP2009522222A/ja active Pending
- 2006-12-22 DE DE502006006013T patent/DE502006006013D1/de active Active
- 2006-12-22 SI SI200630622T patent/SI1968957T1/sl unknown
- 2006-12-22 ES ES06829855T patent/ES2339980T3/es active Active
2008
- 2008-06-26 US US12/147,121 patent/US7871999B2/en not_active Expired - Fee Related
2010
- 2010-04-16 CY CY20101100343T patent/CY1110613T1/el unknown

Also Published As

Publication number	Publication date
WO2007079960A9 (de)	2008-10-23
PT1968957E (pt)	2010-04-26
EP1968957B1 (de)	2010-01-20
JP2009522222A (ja)	2009-06-11
EP1968957A1 (de)	2008-09-17
US7871999B2 (en)	2011-01-18
CY1110613T1 (el)	2015-04-29
WO2007079960A1 (de)	2007-07-19
ES2339980T3 (es)	2010-05-27
US20090176756A1 (en)	2009-07-09
SI1968957T1 (sl)	2010-05-31
DE502006006013D1 (de)	2010-03-11
DK1968957T3 (da)	2010-05-17
DE102005062991A1 (de)	2007-07-05
CA2633731A1 (en)	2007-07-19
ATE455769T1 (de)	2010-02-15

Publication	Publication Date	Title
CY1110613T1 (el)	2015-04-29	Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
IL127296A0 (en)	1999-09-22	Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
DE50302975D1 (de)	2006-05-24	Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
CA2258949A1 (en)	1997-11-06	Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
TW200726765A (en)	2007-07-16	Triazolopyridine cannabinoid receptor 1 antagonists
AU4437896A (en)	1996-07-31	Piperidine derivatives having tachykinin antagonist activity
DE502004006507D1 (de)	2008-04-24	Imidazopyridazinon- und imidazopyridonderivate, deren herstellung und deren verwendung als arzneimittel
NO20062689L (no)	2006-09-12	Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer
NO20062031L (no)	2006-07-06	Derivater av N-[fenyl(alkylptpertdtn-2-yl)metyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske media
NO20072609L (no)	2007-06-19	Malonamid-derivater
BRPI0413233A (pt)	2006-10-03	novos compostos
ATE416157T1 (de)	2008-12-15	Inhibitoren von integrin alpha-v-beta-6
CY1112137T1 (el)	2015-11-04	Υποκατεστημενες σπειρο-ενωσεις και η χρηση αυτων για παραγωγη φαρμακευτικων μεσων εναντι πονου
TW200508207A (en)	2005-03-01	New benzimidazole derivatives
NO20061126L (no)	2006-05-09	Aminopyroner og deres anvendelse som ATM-inhibitorer
ES2098947T3 (es)	1997-05-01	Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
ATE398449T1 (de)	2008-07-15	Verwendung von azetidincarboxamidderivaten in therapie
GB0314967D0 (en)	2003-07-30	Piperazine derivatives
TW200420545A (en)	2004-10-16	1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
NO20022123L (no)	2002-05-03	Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
EP1798227A4 (en)	2009-09-09	SEROTONIN 5-HT3 RECEPTOR AGONIST
ATE399164T1 (de)	2008-07-15	Antagonisten des opioidrezeptors
SI1968963T1 (sl)	2011-11-30	Substituirani amidi propiolne kisline in njihova uporaba za pripravo analgetikov
MY136638A (en)	2008-11-28	New process for the synthesis of perindopril and its pharmaceutically acceptable salts
IL141009A0 (en)	2002-02-10	N-substituted azabicycloheptane derivatives, production and use thereof